Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Aug;38(8):3076-9.
doi: 10.1128/JCM.38.8.3076-3079.2000.

Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area

M Hindiyeh  1 , S Jense, S Hohmann, H Benett, C Edwards, W Aldeen, A Croft, J Daly, S Mottice, K C Carroll
Affiliations
Comparative Study

Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area

M Hindiyeh et al. J Clin Microbiol. 2000 Aug.

Abstract

The Alexon-Trend, Inc. (Ramsey, Minn.), ProSpecT Campylobacter microplate assay was compared with culture on a Campy-CVA plate (Remel, Lenexa, Kans.) and blood-free campylobacter agar with cefoperazone (20 microg/ml), amphotericin B (10 microg/ml), and teicoplanin (4 microg/ml) (CAT medium; Oxoid Limited, Hampshire, England) with 631 patient stool samples. The CAT medium was used to isolate Campylobacter upsaliensis. The enzyme immunoassay (EIA) had a sensitivity and a specificity of 89 and 99%, respectively, and the positive and negative predictive values were 80 and 99%, respectively. Even though we extensively looked for C. upsaliensis in stool samples from patients from the greater Salt Lake City area, we did not isolate this species during the study period. The overall excellent specificity of the EIA allows rapid detection and treatment of positive patients; however, a negative result should be confirmed by culture when clinical suspicion is high.

PubMed Disclaimer

References

    1. Anders B, Lauer B A, Paisley J W, Reller L B. Double-blinded placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet. 1982;1i:131. - PubMed
    1. Aspinall S, Wareing D R A, Hayward P G, Hutchison D N. A comparison of a new campylobacter selective medium (CAT) with membrane filtration for the isolation of thermophilic campylobacters including Campylobacter upsaliensis. J Appl Bacteriol. 1996;80:645–650. - PubMed
    1. Aspinall S, Wareing D R A, Hayward P G, Hutchison D N. Selective medium for thermophilic campylobacters including Campylobacter upsaliensis. J Clin Pathol. 1993;46:829–831. - PMC - PubMed
    1. Baker J, Barton M D, Lanser J. Campylobacter species in cats and dogs in South Australia. Aust Vet J. 1999;77:662–666. - PubMed
    1. Blaser M. Campylobacter jejuni and related species. In: Mandell G L, Bennett J E, Dolin R, editors. Principles and practices of infectious diseases. Vol. 2. Philadelphia, Pa: Churchill Livingstone; 1999. pp. 2276–2285.

Publication types

MeSH terms